Norris Medicines Ltd

₹ 16.1 -1.41%

05 Oct - close price

About

Incorporated in 1990, Norris Medicines
Ltd is a manufacturer of Injections and
Medicinal formulations^[1]

Key Points

Business Overview:^[1]
NML is engaged in the healthcare business.
It carries out contract manufacturing and License Manufacturing for large Multinational
and big Indian Pharma Companies.

Website BSE

Market Cap ₹ 16.1 Cr.
Current Price ₹ 16.1
High / Low ₹ 20.1 / 12.0
Stock P/E
Book Value ₹ -15.1
Dividend Yield 0.00 %
ROCE 3.36 %
ROE %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Debtor days have improved from 69.8 to 52.5 days.

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -7.87% over past five years.
Promoter holding is low: 34.0%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Services Services Commercial Services & Supplies Trading & Distributors

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Figures in Rs. Crores

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	0.95	2.56	0.65	1.49	0.72	1.27	1.11	2.72	1.46	2.00	3.27	1.41	0.92
	1.33	2.80	0.69	1.01	0.88	1.42	1.14	2.65	1.56	2.49	2.32	1.11	1.20
Operating Profit	-0.38	-0.24	-0.04	0.48	-0.16	-0.15	-0.03	0.07	-0.10	-0.49	0.95	0.30	-0.28
OPM %	-40.00%	-9.38%	-6.15%	32.21%	-22.22%	-11.81%	-2.70%	2.57%	-6.85%	-24.50%	29.05%	21.28%	-30.43%
	0.00	0.00	0.00	0.03	0.01	0.00	0.00	0.05	0.02	0.00	0.00	0.02	0.00
Interest	0.09	0.09	0.09	0.11	0.08	0.08	0.12	0.15	0.11	0.11	0.13	0.15	0.00
Depreciation	0.14	0.14	0.14	0.14	0.13	0.13	0.13	0.14	0.12	0.12	0.12	0.12	0.11
Profit before tax	-0.61	-0.47	-0.27	0.26	-0.36	-0.36	-0.28	-0.17	-0.31	-0.72	0.70	0.05	-0.39
Tax %	0.00%	0.00%	0.00%	34.62%	0.00%	0.00%	0.00%	35.29%	0.00%	0.00%	0.00%	0.00%	0.00%
	-0.61	-0.48	-0.27	0.17	-0.37	-0.36	-0.28	-0.23	-0.31	-0.72	0.70	0.05	-0.40
EPS in Rs	-0.61	-0.48	-0.27	0.17	-0.37	-0.36	-0.28	-0.23	-0.31	-0.72	0.70	0.05	-0.40
Raw PDF

Profit & Loss

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
	18.68	18.86	20.46	13.57	16.26	7.84	12.25	9.44	8.36	5.64	5.82	8.13	7.60
	16.97	18.03	20.46	15.49	16.87	10.00	14.00	9.52	7.43	5.81	6.08	7.47	7.12
Operating Profit	1.71	0.83	0.00	-1.92	-0.61	-2.16	-1.75	-0.08	0.93	-0.17	-0.26	0.66	0.48
OPM %	9.15%	4.40%	0.00%	-14.15%	-3.75%	-27.55%	-14.29%	-0.85%	11.12%	-3.01%	-4.47%	8.12%	6.32%
	0.15	0.30	0.06	0.14	0.04	0.09	0.05	0.03	0.01	0.01	0.06	0.05	0.02
Interest	0.54	0.67	0.60	0.70	0.73	0.88	1.63	1.48	1.50	0.37	0.44	0.50	0.39
Depreciation	1.31	0.60	0.65	0.71	0.71	0.73	0.67	0.66	0.63	0.57	0.54	0.49	0.47
Profit before tax	0.01	-0.14	-1.19	-3.19	-2.01	-3.68	-4.00	-2.19	-1.19	-1.10	-1.18	-0.28	-0.36
Tax %	10,500.00%	-128.57%	-35.29%	-21.00%	-16.42%	-22.83%	24.25%	49.32%	47.06%	8.18%	5.08%	0.00%
	-1.04	0.04	-0.77	-2.51	-1.68	-2.84	-4.96	-3.26	-1.75	-1.19	-1.24	-0.28	-0.37
EPS in Rs	-1.04	0.04	-0.77	-2.51	-1.68	-2.84	-4.96	-3.26	-1.75	-1.19	-1.24	-0.28	-0.37
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	-8%
5 Years:	-8%
3 Years:	-1%
TTM:	16%

Compounded Profit Growth
10 Years:	%
5 Years:	14%
3 Years:	23%
TTM:	69%

Stock Price CAGR
10 Years:	%
5 Years:	9%
3 Years:	9%
1 Year:	-1%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	9.93	9.93	9.93	9.93	9.93	9.93	9.93	9.93	9.93	9.93	9.93	9.93
Reserves	-4.63	-4.60	-5.36	-7.88	-9.55	-12.39	-17.36	-20.62	-22.37	-23.56	-24.79	-25.07
	8.16	7.51	7.57	7.71	11.24	17.92	15.52	21.08	21.40	21.52	21.58	21.53
	4.69	5.06	9.90	10.92	8.76	5.10	11.69	3.80	4.72	6.29	7.09	6.50
Total Liabilities	18.15	17.90	22.04	20.68	20.38	20.56	19.78	14.19	13.68	14.18	13.81	12.89
	8.61	8.34	9.97	9.32	8.90	8.25	7.67	7.07	6.47	5.79	5.27	4.79
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
	9.53	9.55	12.06	11.35	11.47	12.30	12.10	7.11	7.20	8.38	8.53	8.09
Total Assets	18.15	17.90	22.04	20.68	20.38	20.56	19.78	14.19	13.68	14.18	13.81	12.89

Cash Flows

Figures in Rs. Crores

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	-1.43	1.35	-0.96	0.80	-1.92	-2.88	1.11	-1.01	1.20	0.17	0.51	0.59
	-0.88	-0.34	-2.05	-0.08	-0.29	0.00	-0.06	-0.09	-0.02	0.05	0.00	-0.09
	0.10	-1.32	3.16	-0.66	2.18	2.86	-1.09	1.10	-1.18	-0.20	-0.50	-0.52
Net Cash Flow	-2.21	-0.31	0.15	0.06	-0.02	-0.02	-0.04	0.00	0.00	0.02	0.00	-0.02
Free Cash Flow	-2.30	1.03	-3.24	0.74	-2.21	-2.96	1.02	-1.07	1.17	0.26	0.49	0.58
CFO/OP	-84%	163%		-42%	315%	133%	-63%	1,262%	129%	-100%	-196%	89%

Ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	73.66	53.61	84.20	66.44	67.57	128.49	53.33	42.15	48.03	68.60	88.43	52.53
Inventory Days	100.05	134.23	129.50	238.53	134.81	323.82	212.99	157.45	347.62	594.15	436.94	337.84
Days Payable	111.66	99.30	125.29	252.40	139.83	233.37	218.83	86.53	149.91	244.25	320.57	222.40
Cash Conversion Cycle	62.06	88.54	88.41	52.56	62.55	218.94	47.49	113.06	245.73	418.51	204.80	167.97
Working Capital Days	27.75	34.84	-16.06	-91.18	-32.55	-30.73	-103.69	-97.82	-122.25	-202.56	-240.82	-167.46
ROCE %	4.02%	4.03%	-4.08%	-22.92%	-11.97%	-20.68%	-20.13%	-7.68%	3.20%	-8.43%	-10.13%	3.36%

Insights

In beta

Mar 2019

Mar 2020

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Export Revenue (FOB) as % of Revenue from Operations
%

x.xx	x.xx	x.xx	x.xx	x.xx	x.xx	xx.xx
xx	xx	xx	xx	xx	xx	xx
		x.xx	x.xx	x.xx	x.xx	x.xx

Please log in to see hidden values.

Number of Permanent Employees
count

Job Work Sales as % of Revenue from Operations
%

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	34.01%	34.01%	34.01%	34.01%	34.01%	34.00%	34.00%	34.00%	34.00%	34.00%	34.01%	34.01%
	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%
	65.91%	65.91%	65.91%	65.90%	65.91%	65.92%	65.93%	65.93%	65.92%	65.92%	65.90%	65.90%
No. of Shareholders	25,242	25,317	25,517	25,400	25,498	25,659	25,815	25,950	25,895	25,791	25,777	25,777

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	Jun 2026
	34.04%	34.04%	34.04%	10.44%	34.04%	34.04%	34.04%	34.01%	34.00%	34.01%	34.01%
	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%	0.07%
	65.89%	65.89%	65.89%	89.49%	65.89%	65.89%	65.88%	65.91%	65.93%	65.90%	65.90%
No. of Shareholders	25,798	25,774	25,422	25,193	25,010	25,290	25,326	25,517	25,815	25,777	25,777

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

Norris Medicines Ltd

Norris Medicines Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Insights

Shareholding Pattern

Documents

Announcements

Annual reports